Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: Tapering versus abrupt discontinuation

European Journal of Clinical Pharmacology

Volumn 61, Issue 4, 2005, Pages 303-307

  Van Geffen, E C G ^a,b   Hugtenburg, J G ^a   Heerdink, E R ^a   Van Hulten, R P ^a   Egberts, A C G ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Discontinuation symptoms; SSRI; Tapering

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL PRACTICE; CONFUSION; CONTROLLED STUDY; CRYING; DIZZINESS; DRUG EFFECT; FEMALE; HEADACHE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; NERVOUSNESS; PATIENT COUNSELING; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; SLEEP DISORDER; VOMITING;

ADULT; CITALOPRAM; DEPRESSION; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PAROXETINE; QUALITY OF LIFE; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 21244496007     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0921-x     Document Type: Article

References (15)

1. Rosenbaum JF, Zajecka J (1997) Clinical management of antidepressant discontinuation. J Clin Psychiatry 58:37-40
2. Lejoyeux M, Adès J (1997) Antidepressants discontinuation: a review of the literature. J Clin Psychiatry 58:11-16
3. Haddad PM (2001) Antidepressant discontinuation syndromes. Clinical relevance, prevention and management. Drug Saf 24:183-197
4. Price JS, Waller PC, Wood SM, MacKay AV (1996) A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 42:757-763
5. Schatzberg AF, Haddad PM, Kaplan EM, Lejoyeux M, Rosenbaum JF, Young AH, Zajecka J (1997) Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. J Clin Psychiatry 58:23-27
6. Einbinder E (1995) Fluoxetine withdrawal. Am J Psychiatry 152:1235
7. Black DW, Wesner R, Gabel J (1993) The abrupt discontinuation of fluvoxamine in patients with panic disorder. J Clin Psychiatry 54:146-149
8. Rosenstock HA (1996) Sertraline withdrawal in two brothers: a case report. Int Clin Psychopharmacol 11:58-59
9. Anderson IM, Nutt DJ, Deakin JFW (2000) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J Psychopharmacol 14:3-20
10. Anonymous (1999) Withdrawing patients from antidepressants. Drug Ther Bull 37:49-52
11. Young AH, Currie A (1997) Physicians' knowledge of antidepressant withdrawal effects: a survey. J Clin Psychiatry 58:28-30
12. Demyttenaere K, Enzlin P, Dewé W, Boulanger B, Bie JD, Troyer WD, Mesters P (2001) Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry 62:30-33
13. Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, Fireman B (2002) Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 288:1403-1409
14. Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB (1998) Selective serotonin reuptake inhibitor discontinuation syndrome: a randomised clinical trial. Biol Psychiatry 44:77-87
15. Haddad PM, Devarajan S, Dursun SM (2001) Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'. J Psychopharmacol 15:139-141